Results 21 to 30 of about 16,709 (213)

Pharmacological inhibition of bromodomain-containing proteins in inflammation. [PDF]

open access: yesCold Spring Harb Perspect Biol, 2014
Inflammation is associated with the activation of genes that contribute to immune defense and tissue repair. The bromodomain-containing proteins of the BET family, which recognize histone lysine acetylation, play a key role in the transcriptional control of inflammatory genes. Inhibition of BET proteins by the small-molecule inhibitor I-BET affects the
Schaefer U.
europepmc   +4 more sources

Applying ⁸⁹Zr-Transferrin To Study the Pharmacology of Inhibitors to BET Bromodomain Containing Proteins. [PDF]

open access: yesMol Pharm, 2016
Chromatin modifying proteins are attractive drug targets in oncology, given the fundamental reliance of cancer on altered transcriptional activity. Multiple transcription factors can be impacted downstream of primary target inhibition, thus making it ...
Doran MG   +8 more
europepmc   +2 more sources

Design and synthesis of small molecule chemical probes for bromodomain-containing proteins

open access: yes, 2014
Bromodomains (BRDs) are protein modules which bind to acetylated lysines on histones and transcriptional regulating proteins. BRD-containing proteins are involved in a large variety of critical cellular processes and their misregulation, or mutation of ...
Hay, Duncan A
core   +2 more sources

USP24 stabilizes bromodomain containing proteins to promote lung cancer malignancy. [PDF]

open access: yesSci Rep, 2020
AbstractBromodomain (BRD)-containing proteins are important for chromatin remodeling to regulate gene expression. In this study, we found that the deubiquitinase USP24 interacted with BRD through its C-terminus increased the levels of most BRD-containing proteins through increasing their protein stability by the removal of ubiquitin from Lys391/Lys400 ...
Wang SA   +4 more
europepmc   +4 more sources

Bromodomain-Containing Protein BRD4 Is Hyperphosphorylated in Mitosis [PDF]

open access: yesCancers, 2020
The epigenetic reader BRD4 binds acetylated histones and plays a central role in controlling cellular gene transcription and proliferation. Dysregulation of BRD4′s activity has been implicated in the pathogenesis of a wide variety of cancers. While blocking BRD4 interaction with acetylated histones using BET inhibitors (BETis) has been tested in ...
Ranran Wang   +4 more
openaire   +2 more sources

Bromodomain-containing protein BRPF1 is a therapeutic target for liver cancer [PDF]

open access: yesCommunications Biology, 2021
AbstractEpigenetic deregulation plays an essential role in hepatocellular carcinoma (HCC) progression. Bromodomains are epigenetic “readers” of histone acetylation. Recently, bromodomain inhibitors have exhibited promising therapeutic potential for cancer treatment.
Carol Lai-Hung Cheng   +10 more
openaire   +3 more sources

The BRPF1 bromodomain is a molecular reader of di-acetyllysine

open access: yesCurrent Research in Structural Biology, 2020
Bromodomain-containing proteins are often part of chromatin-modifying complexes, and their activity can lead to altered expression of genes that drive cancer, inflammation and neurological disorders in humans.
Juliet O. Obi   +10 more
doaj   +1 more source

BET Bromodomain Inhibitors: Novel Design Strategies and Therapeutic Applications

open access: yesMolecules, 2023
The mammalian bromodomain and extra-terminal domain (BET) family of proteins consists of four conserved members (Brd2, Brd3, Brd4, and Brdt) that regulate numerous cancer-related and immunity-associated genes.
Kenneth K. W. To   +3 more
doaj   +1 more source

Bromodomain-Containing Protein 4 [PDF]

open access: yesCirculation Research, 2015
Rationale: Pulmonary arterial hypertension (PAH) is a vasculopathy characterized by enhanced pulmonary artery (PA) smooth muscle cell (PASMC) proliferation and suppressed apoptosis. Decreased expression of microRNA-204 has been associated to this phenotype.
Jolyane, Meloche   +15 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy